MedTrace Logo

Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face

NCT01995604 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-06-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of dHACM (Dehydrated Human Amnion Chorion Membrane) for reducing time to healing when used in post-laser recovery following ActiveFX™ and DeepFx™ fractionated ablative CO2 laser resurfacing of the face.

Conditions

  • Scarring

Interventions

OTHER

Application of Sterile 0.9% Saline Solution

Application of Sterile 0.9% Saline Solution to half of face after UltraPulse laser therapy.

OTHER

Application of dHACM

Application of dHACM to half of face after UltraPulse laser therapy.

Sponsors & Collaborators

  • MiMedx Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Mitchel P Goldman, MD · Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01995604 on ClinicalTrials.gov